Arcturus Therapeutics has built a multicultural team, based in San Diego, CA, USA
We have an exciting COVID-19 vaccine candidate that we hope will make a positive difference in the pandemic
See our team describe what it means for them to help get a vaccine to protect people around the world-no matter where you are from
A
S
L
https://arcturusrx.com/wp-content/uploads/2020/07/JoePayne_LanguageProficiency_V3_1.mp4
arabic
(عربى)
https://arcturusrx.com/wp-content/uploads/2020/07/MaherA_LanguageProficiency_V3_1.mp4
chinese
(中文)
https://arcturusrx.com/wp-content/uploads/2020/07/thumbnail_BelleBao.jpg,https://arcturusrx.com/wp-content/uploads/2020/07/BelleBao_LanguageProficiency__V3_1.mp4
https://arcturusrx.com/wp-content/uploads/2020/07/thumbnail_HowardYu.jpg,https://arcturusrx.com/wp-content/uploads/2020/07/HowardYu_LanguageProficiency_V3_1.mp4
https://arcturusrx.com/wp-content/uploads/2020/07/thumbnail_YurongGuo.jpg,https://arcturusrx.com/wp-content/uploads/2020/07/YurongGuo_LanguageProficiency_V3_1.mp4
https://arcturusrx.com/wp-content/uploads/2020/07/thumbnail_XuefengGuo.jpg,https://arcturusrx.com/wp-content/uploads/2020/07/XuefengGuo_LanguageProficiency_V3_1.mp4
english
(British)
https://arcturusrx.com/wp-content/uploads/2020/07/MikeHodges_LanguageProficiency_V3_1.mp4
farsi
(فارسی)
https://arcturusrx.com/wp-content/uploads/2021/01/NedaSafarzadeh_LanguageProficiency_V4.mp4
french
(Français)
https://arcturusrx.com/wp-content/uploads/2020/07/NadjaEl-mecharrafie_LanguageProficiency_V3_1.mp4
german
(deutsch)
https://arcturusrx.com/wp-content/uploads/2020/07/LisaKieweg-Thompson_LanguageProficiency_V3_1.mp4
hebrew
(עִברִית)
https://arcturusrx.com/wp-content/uploads/2020/07/thumbnail_NoaScott.jpg,https://arcturusrx.com/wp-content/uploads/2020/07/NoaScott_LanguageProficiency_V3_1.mp4
https://arcturusrx.com/wp-content/uploads/2020/07/thumbnail_TamarGrossman.jpg,https://arcturusrx.com/wp-content/uploads/2020/07/TamarGrossman_LanguageProficiency_V3_1.mp4
hindi
(हिन्दी)
https://arcturusrx.com/wp-content/uploads/2020/07/PriyaKarmali_LanguageProficiency_V3_1.mp4
italian
(italiano)
https://arcturusrx.com/wp-content/uploads/2020/07/thumbnail_CristianoSacchetti.jpg,https://arcturusrx.com/wp-content/uploads/2020/07/CristianoSacchetti_LanguageProficiency_V3_1.mp4
https://arcturusrx.com/wp-content/uploads/2020/07/thumbnail_GiulioCattarossi.jpg,https://arcturusrx.com/wp-content/uploads/2020/07/GiulioCattarossi_LanguageProficiency_V3_1.mp4
Japanese
(日本語)
https://arcturusrx.com/wp-content/uploads/2020/09/Kiyoshi_Tachikawa_v2.mp4
korean
(한국어)
https://arcturusrx.com/wp-content/uploads/2020/07/JaeHeonKim_LanguageProficiency_V3_1.mp4
portuguese
(Português)
https://arcturusrx.com/wp-content/uploads/2020/07/RamonDiazTrelles_LanguageProficiency_V3_1.mp4
spanish
(español)
https://arcturusrx.com/wp-content/uploads/2020/07/CarlosPerezGarcia_LanguageProficiency__V3_1.mp4
vietnamese
(Tiếng Việt)
https://arcturusrx.com/wp-content/uploads/2020/07/HannahHuynh_LanguageProficiency_V3_1.mp4
Grishma Acharya, Scientist II, Pharmacologist
Grishma Acharya, Scientist II, Pharmacologist
Suzan Alayian, Accounts Payable Specialist
Suzan Alayian, Accounts Payable Specialist
Maher Alayyoubi, Scientist II, RNA Process Development
Maher Alayyoubi, Scientist II, RNA Process Development
Elizabeth Allen, Senior Research Associate, Frontier Science
Elizabeth Allen, Senior Research Associate, Frontier Science
Yanjie (Belle) Bao, Associate Director, Formulation & Process Development
Yanjie (Belle) Bao, Associate Director, Formulation & Process Development
James Barlow, Director of the Board
James Barlow, Director of the BoardBio
Dina Berdieva, Vice President, Clinical Operations
Dina Berdieva, Vice President, Clinical OperationsBio
Natasha Bowman, Vice President, Head of Human Resources
Natasha Bowman, Vice President, Head of Human ResourcesBio
Juthamart Brady, Research Associate, Drug Discovery
Juthamart Brady, Research Associate, Drug Discovery
Giulio Cattarossi, Senior Research Associate, RNA Sciences
Giulio Cattarossi, Senior Research Associate, RNA Sciences
Lena Ceballos, Public Relations & Marketing Specialist
Lena Ceballos, Public Relations & Marketing Specialist
Emily Chao, Research Associate I, Frontier Science
Emily Chao, Research Associate I, Frontier Science
Brandon Chen, Analyst Investor Relations/Public Relations
Brandon Chen, Analyst Investor Relations/Public Relations
Pad Chivukula, CSO, COO
Pad Chivukula, CSO, COOBio
Brenda Clemente, Manager, Formulation & Process Development
Brenda Clemente, Manager, Formulation & Process Development
Diana Correa, Research Assistant, Analytical Development
Diana Correa, Research Assistant, Analytical Development
Alex Daily, Purchasing Manager
Alex Daily, Purchasing Manager
Michael Davis, Research Assistant, Formulation Development
Michael Davis, Research Assistant, Formulation Development
ThanhChau Dam, Sr. Research Associate, Translational Biology
ThanhChau Dam, Sr. Research Associate, Translational Biology
Michael Delbuono, Research Associate I, Analytical Development
Michael Delbuono, Research Associate I, Analytical Development
Yisong Deng, Scientist I, Analytical Development
Yisong Deng, Scientist I, Analytical Development
Nadja El-Mecharrafie, Research Associate II, Frontier Science
Nadja El-Mecharrafie, Research Associate II, Frontier Science
Peter Farrell, Chairman of the Board
Peter Farrell, Chairman of the BoardBio
Adam Finochio, Research Assistant, Formulation Development
Adam Finochio, Research Assistant, Formulation Development
David Geller, Vice President, Clinical Development for Pulmonary and Rare Diseases
David Geller, Vice President, Clinical Development for Pulmonary and Rare DiseasesBio
Kyra Gillard, Research Associate I, Formulation Development
Kyra Gillard, Research Associate I, Formulation Development
Abraham Gomez, Senior Research Associate, Translational Biology
Abraham Gomez, Senior Research Associate, Translational Biology
Ayelet Gonen, Senior Scientist, Pharmacologist, Translational Biology
Ayelet Gonen, Senior Scientist, Pharmacologist, Translational Biology
Jose Gonzales, Sr. Research Associate
Jose Gonzales, Sr. Research Associate
Tamar Grossman, Head of Rare Diseases
Tamar Grossman, Head of Rare Diseases
Yurong Guo, Senior Manager, Analytical Development and QC
Yurong Guo, Senior Manager, Analytical Development and QC
Paula Hartman, Sr. Research Associate, RNA Sciences
Paula Hartman, Sr. Research Associate, RNA Sciences
JP Headley, Director, Accounting and Operations
JP Headley, Director, Accounting and Operations
Michael Hodges, R&D & Medical Consultant
Michael Hodges, R&D & Medical ConsultantBio
Dr. Ed Holmes, Director of the Board
Dr. Ed Holmes, Director of the BoardBio
Hyojung Hong, Research Associate I, Formulation Development
Hyojung Hong, Research Associate I, Formulation Development
Dr. Steve Hughes, Chief Medical Officer
Dr. Steve Hughes, Chief Medical OfficerBio
Hannah Huynh, Laboratory Coordinator
Hannah Huynh, Laboratory Coordinator
Daniel Hwang, Accounting Supervisor
Daniel Hwang, Accounting Supervisor
Priya Karmali, VP, Technology Innovation and Development
Priya Karmali, VP, Technology Innovation and DevelopmentBio
Lisa Kieweg-Thompson, Research Associate II, RNA Production
Lisa Kieweg-Thompson, Research Associate II, RNA Production
Jae Heon (Jay) Kim, Research Associate I, Formulation Development
Jae Heon (Jay) Kim, Research Associate I, Formulation Development
Michelle Kim, Research Associate I, Analytical Development
Michelle Kim, Research Associate I, Analytical Development
Mukunda Krishna, Senior Process Engineer II, Technical Transfer
Mukunda Krishna, Senior Process Engineer II, Technical Transfer
Kristen Kuakini, Research Associate II
Kristen Kuakini, Research Associate II
Greg Kubczak, Director, Technical Services and Manufacturing
Greg Kubczak, Director, Technical Services and Manufacturing
KC Kummerfeld, Vice President, Finance & Corporate Controller
KC Kummerfeld, Vice President, Finance & Corporate ControllerBio
Yi Kuo, Research Associate II
Yi Kuo, Research Associate II
Lance Kurata, Chief Legal Officer
Lance Kurata, Chief Legal OfficerBio
Robin Lee, Senior Research Associate, Analytical Development
Robin Lee, Senior Research Associate, Analytical Development
Maral Llewellyn, Senior Scientist, Bioanalytical
Maral Llewellyn, Senior Scientist, Bioanalytical
Angel Leu, Senior Research Associate, Frontier Science
Angel Leu, Senior Research Associate, Frontier Science
Pattraranee (Patty) Limphong, Associate Director, Drug Discovery
Pattraranee (Patty) Limphong, Associate Director, Drug Discovery
Kelly Lindert, Senior Vice President, Head of Vaccine Clinical Development
Kelly Lindert, Senior Vice President, Head of Vaccine Clinical DevelopmentBio
Rob Lopez, Facilities-Shipping & Receiving
Rob Lopez, Facilities-Shipping & Receiving
Tim Luger, Research Associate II, RNA Process Development
Tim Luger, Research Associate II, RNA Process Development
Dr. Magda Marquet, Director of the Board
Dr. Magda Marquet, Director of the BoardBio
Daiki Matsuda, Associate Director, Frontier Science
Daiki Matsuda, Associate Director, Frontier Science
Alana Montoya, Senior Research Associate, RNA Production
Alana Montoya, Senior Research Associate, RNA Production
Rajesh Mukthavaram, Scientist II, Formulation Development
Rajesh Mukthavaram, Scientist II, Formulation Development
Andy Ngo, Research Associate I, RNA Production
Andy Ngo, Research Associate I, RNA Production
Michelle Nguyen, Senior Research Associate, Analytical Development
Michelle Nguyen, Senior Research Associate, Analytical Development
Cristine Ohlson, Contracts Administrator/Paralegal
Cristine Ohlson, Contracts Administrator/Paralegal
Mario Ornelas, Quality Manager, Quality & Regulatory
Mario Ornelas, Quality Manager, Quality & Regulatory
Jenny Park, Scientist II
Jenny Park, Scientist II
Jinho Park, Scientist I, Formulation Development
Jinho Park, Scientist I, Formulation Development
Suezanne Parker, Senior Vice President, Translational Biology
Suezanne Parker, Senior Vice President, Translational BiologyBio
Deep Patel, Manager, CMC Operations
Deep Patel, Manager, CMC Operations
Joseph E. Payne, President & CEO, Director of the Board
Joseph E. Payne, President & CEO, Director of the BoardBio
Yihua Pei, Scientist I, Formulation Development
Yihua Pei, Scientist I, Formulation Development
Carlos Perez-Garcia, Senior Scientist, Translational Biology
Carlos Perez-Garcia, Senior Scientist, Translational Biology
Edgardo Pica, Research Associate I, Analytical Development
Edgardo Pica, Research Associate I, Analytical Development
Linda Quirino, Senior Research Associate, Translational Biology
Linda Quirino, Senior Research Associate, Translational Biology
Huda Rabi, Research Associate I, Formulation Development
Huda Rabi, Research Associate I, Formulation Development
Kumar Rajappan, Principal Scientist, Chemistry
Kumar Rajappan, Principal Scientist, Chemistry
Tyler Raymer, Senior Manager, Facilities
Tyler Raymer, Senior Manager, Facilities
River Recatto, Research Associate I, Formulation Development
River Recatto, Research Associate I, Formulation Development
Paloma Martinez Redondo, Scientist II, Translational Biology
Paloma Martinez Redondo, Scientist II, Translational Biology
Janet Reed, Executive Assistant
Janet Reed, Executive Assistant
Pamela Resch, Executive Director, Quality and Regulatory Affairs
Pamela Resch, Executive Director, Quality and Regulatory Affairs
Josie Rivera, Research Associate I
Josie Rivera, Research Associate I
Joseph Roberts, Assistant Controller
Joseph Roberts, Assistant Controller
Scott Roberts, Director, CMC Operations and Supply Chain
Scott Roberts, Director, CMC Operations and Supply Chain
Fred del Rosario, Senior Director, Information Technology
Fred del Rosario, Senior Director, Information Technology
Sunil Raju, VP, Head of Drug Safety and Pharmacovigilance
Sunil Raju, VP, Head of Drug Safety and PharmacovigilanceBio
Qian Ruan, VP, Technical Operations & Manufacturing
Qian Ruan, VP, Technical Operations & ManufacturingBio
Marciano Sablad, Associate Director, Translational Biology
Marciano Sablad, Associate Director, Translational Biology
Cristiano Sacchetti, Senior Scientist, Bioanalytical
Cristiano Sacchetti, Senior Scientist, Bioanalytical
Neda Safarzadeh, Senior Director, Head of Investor Relations/Public Relations/Marketing
Neda Safarzadeh, Senior Director, Head of Investor Relations/Public Relations/Marketing
Hazel Santos, Accounts Payable Specialist
Hazel Santos, Accounts Payable Specialist
Andrew Sassine, Chief Financial Officer
Andrew Sassine, Chief Financial Officer
Noa Scott, Human Resources Specialist
Noa Scott, Human Resources Specialist
Kyle Scurlock, Senior Accountant
Kyle Scurlock, Senior Accountant
Rose Sekulovich, Executive Director, Bioanalytical
Rose Sekulovich, Executive Director, Bioanalytical
Henry Shafron, Research Assistant, Analytical Development
Henry Shafron, Research Assistant, Analytical Development
Kevin Skol, Senior Vice President, Business Development & Alliance Management
Kevin Skol, Senior Vice President, Business Development & Alliance ManagementBio
Claine Snow, Sr. IP & Transactions Counsel
Claine Snow, Sr. IP & Transactions Counsel
Tyler Spencer, Senior Financial Analyst
Tyler Spencer, Senior Financial Analyst
Sean Sullivan, Executive Director, Process Development
Sean Sullivan, Executive Director, Process Development
Jocelyn Tabaldo, Administrative Assistant
Jocelyn Tabaldo, Administrative Assistant
Kiyoshi Tachikawa, Senior Research Fellow, Frontier Science
Kiyoshi Tachikawa, Senior Research Fellow, Frontier Science
Wendy Taylor, Executive Director, Program Management
Wendy Taylor, Executive Director, Program Management
Phuong-Danh Tran, Research Associate I, Formulation Development
Phuong-Danh Tran, Research Associate I, Formulation Development
Ramon Diaz Trelles, Senior Scientist, Frontier Science
Ramon Diaz Trelles, Senior Scientist, Frontier Science
Jerel Vega, Senior Manager, CMC Operations
Jerel Vega, Senior Manager, CMC Operations
Andres Valderrama, Scientist II, Frontier Science
Andres Valderrama, Scientist II, Frontier Science
Dushyant Varshney, Executive Vice President & Chief Technology Officer
Dushyant Varshney, Executive Vice President & Chief Technology OfficerBio
Simone Ward, Life Sciences Patent Attorney
Simone Ward, Life Sciences Patent Attorney
Rodrigo Yelin, Associate Director, Program Management
Rodrigo Yelin, Associate Director, Program Management
Howard Yu, Senior Scientist, Bioanalytical
Howard Yu, Senior Scientist, Bioanalytical

Founded in 2013 and based in San Diego, California, Arcturus Therapeutics is an industry leader in the application of RNA technologies for the treatment of disease and improved quality of life. The company’s aim is to develop breakthrough technology and novel therapeutics for rare diseases for which there is no adequate treatment. Backed by a management team with extensive experience in the discovery and development of RNA medicines, Arcturus is on the forefront of research and development of RNA chemistry and delivery technologies.

 

News & Events
March 4, 2013
Arcturus Therapeutics Begins Operations in Janssen Labs
READ MORE
May 8, 2013
Arcturus Therapeutics Announces New Appointments to its Board of Directors and Scientific Advisory Board
READ MORE
June 1, 2013
Arcturus Therapeutics Raises $1.3 Million in Series Seed Funding
READ MORE
June 3, 2013
With $1.3M in Seed Funding, Arcturus Adds to RNAi Hub in San Diego
READ MORE
October 1, 2020
Arcturus Therapeutics to Present at Guggenheim’s Vaccines and Infectious Diseases Conference
READ MORE
October 5, 2020
Arcturus Therapeutics Announces Completion of First Three Dose Escalation Cohorts in Phase 1 Study of ARCT-810, Therapeutic Candidate for Ornithine Transcarbamylase (OTC) Deficiency
READ MORE
October 6, 2020
Recipharm signs agreement with Arcturus Therapeutics to support the manufacture of LUNAR®-COV19 (ARCT-021) vaccine candidate
READ MORE
October 30, 2020
Arcturus Therapeutics to Report Third Quarter 2020 Financial Results and Provide Corporate Update on Nov 9, 2020
READ MORE
November 4, 2020
Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences
READ MORE
November 9, 2020
Arcturus Therapeutics Announces Positive Interim ARCT-021 (LUNAR-COV19) Phase 1/2 Study Results for Both Single Shot and Prime-boost Regimens, and Up to $220 Million in Additional Financial Commitments from Singapore
READ MORE
November 9, 2020
Arcturus Therapeutics Announces Third Quarter 2020 Financial Results and Positive Clinical Updates for ARCT-810 Phase I Study and Additional ARCT-021 Interim Data
READ MORE
November 30, 2020
Arcturus Therapeutics to Present at Upcoming Investor Conference
READ MORE
December 7, 2020
Arcturus Therapeutics Announces Initiation of Dosing ARCT-810 in Patients with Ornithine Transcarbamylase (OTC) Deficiency
READ MORE
December 7, 2020
Arcturus Therapeutics Announces Proposed Public Offering of Common Stock
READ MORE
December 7, 2020
Arcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
READ MORE
December 28, 2020
Arcturus Therapeutics Received Approval from Singapore Health Sciences Authority to Proceed with Phase 2 Study of ARCT-021 (LUNAR-COV19) Vaccine Candidate and Provides New and Updated Clinical and Preclinical Data
READ MORE
December 30, 2020
Arcturus Therapeutics to Advance ARCT-032, an Aerosolized LUNAR® mRNA-based Therapeutic, as a Development Candidate for Cystic Fibrosis Lung Disease
READ MORE
January 4, 2021
Arcturus Therapeutics Receives FDA Allowance to Proceed with Phase 2 Study of ARCT-021 (LUNAR-COV19) Vaccine Candidate in the United States
READ MORE
January 6, 2021
Arcturus Therapeutics to Present at Upcoming Investor Conference
READ MORE
February 11, 2021
Arcturus Therapeutics to Present at Upcoming Investor Conferences
READ MORE
February 19, 2021
Arcturus Therapeutics to Report Fourth Quarter and Year-End 2020 Financial Results and Provide Corporate Update on March 1, 2021
READ MORE
February 22, 2021
Arcturus Therapeutics Acquires Exclusive License to mRNA Manufacturing Technology from Alexion Pharmaceuticals
READ MORE
March 1, 2021
Arcturus Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Positive Clinical Updates
READ MORE
March 30, 2021
Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences
READ MORE
X